Icosavax, Inc.
ICVX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$91,758 | -$66,971 | -$18,854 | -$5,297 |
| Dep. & Amort. | $860 | $82 | $1 | $0 |
| Deferred Tax | $0 | $959 | -$187 | $0 |
| Stock-Based Comp. | $21,694 | $29,031 | $257 | $72 |
| Change in WC | $8,074 | -$1,905 | $4,158 | $656 |
| Other Non-Cash | -$545 | $264 | $417 | $0 |
| Operating Cash Flow | -$61,675 | -$38,540 | -$14,208 | -$4,569 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$11,113 | -$1,006 | -$11 | $0 |
| Net Acquisitions | $158,336 | $0 | $0 | $0 |
| Inv. Purchases | -$221,086 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $62,750 | $0 | $0 | $0 |
| Other Inv. Act. | -$158,336 | $0 | $0 | $0 |
| Investing Cash Flow | -$169,449 | -$1,006 | -$11 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $190,738 | $174 | $26,742 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $10,307 | $304,772 | $6,638 | $26,742 |
| Financing Cash Flow | $10,307 | $304,772 | $6,638 | $26,742 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$220,817 | $265,226 | -$7,581 | $22,173 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $280,724 | $15,498 | $23,079 | $906 |
| End Cash | $59,907 | $280,724 | $15,498 | $23,079 |
| Free Cash Flow | -$72,788 | -$39,546 | -$14,219 | -$4,569 |